1.58
price down icon1.25%   -0.02
after-market 시간 외 거래: 1.60 0.02 +1.27%
loading
전일 마감가:
$1.60
열려 있는:
$1.67
하루 거래량:
1.89M
Relative Volume:
0.66
시가총액:
$157.65M
수익:
-
순이익/손실:
$-37.34M
주가수익비율:
-1.1618
EPS:
-1.36
순현금흐름:
$-36.91M
1주 성능:
-4.82%
1개월 성능:
-24.40%
6개월 성능:
+15.33%
1년 성능:
+31.67%
1일 변동 폭
Value
$1.57
$1.67
1주일 범위
Value
$1.56
$1.675
52주 변동 폭
Value
$0.772
$2.2691

Sellas Life Sciences Group Inc Stock (SLS) Company Profile

Name
명칭
Sellas Life Sciences Group Inc
Name
전화
(646) 200-5278
Name
주소
7 TIMES SQUARE, NEW YORK, NY
Name
직원
15
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
SLS's Discussions on Twitter

SLS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
SLS
Sellas Life Sciences Group Inc
1.58 158.65M 0 -37.34M -36.91M -1.36
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
366.54 98.88B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.00 58.84B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
438.93 56.12B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
661.83 41.20B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
288.18 35.49B 3.81B -644.79M -669.77M -6.24

Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-07-21 개시 Cantor Fitzgerald Overweight
2018-11-01 개시 Oppenheimer Outperform
2018-04-02 개시 H.C. Wainwright Buy
2018-03-19 업그레이드 Maxim Group Hold → Buy

Sellas Life Sciences Group Inc 주식(SLS)의 최신 뉴스

pulisher
Aug 09, 2025

Sellas Life Sciences' GPS Trial Continues with Positive IDMC Recommendation - AInvest

Aug 09, 2025
pulisher
Aug 09, 2025

SELLAS Life Sciences Receives Positive IDMC Recommendation to Continue Phase 3 REGAL Trial of GPS in AML. - AInvest

Aug 09, 2025
pulisher
Aug 07, 2025

SELLAS Life Sciences Gets Positive IDMC Nod To Continue Phase 3 Trial Of AML Treatment - Nasdaq

Aug 07, 2025
pulisher
Aug 07, 2025

IDMC recommends continuation of Phase 3 AML trial for galinpepimut-S - Investing.com India

Aug 07, 2025
pulisher
Aug 07, 2025

SELLAS Life Sciences Announces Independent Data Monitoring - GlobeNewswire

Aug 07, 2025
pulisher
Aug 07, 2025

SELLAS Phase 3 Cancer Drug GPS Clears Critical Safety Review, Final Data Expected This Year - Stock Titan

Aug 07, 2025
pulisher
Aug 04, 2025

SELLAS Life Sciences Group Inc. Consolidation Zone May Signal AccumulationMulti-Bagger Potential Stock Forecast Tools Released - metal.it

Aug 04, 2025
pulisher
Aug 03, 2025

What institutional investors are buying SELLAS Life Sciences Group Inc. stockGet alerts on top growth stocks daily - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about SELLAS Life Sciences Group Inc. stockDiscover investment plans that deliver results - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Does SELLAS Life Sciences Group Inc. stock perform well during market downturnsExceptional profit velocity - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does SELLAS Life Sciences Group Inc. compare to its industry peersBreakout stock performance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the latest earnings results for SELLAS Life Sciences Group Inc.Achieve fast wealth growth with smart picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for SELLAS Life Sciences Group Inc. in the next 12 monthsRapid profit acceleration - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What makes SELLAS Life Sciences Group Inc. stock price move sharplyGet professional advice for portfolio optimization - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are SELLAS Life Sciences Group Inc. company’s key revenue driversInvest smarter with daily stock recommendations - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

SELLAS Life Sciences Group (SLS) Upgraded to Buy: What Does It Mean for the Stock? (Revised) - MSN

Aug 01, 2025
pulisher
Aug 01, 2025

What is the dividend policy of SELLAS Life Sciences Group Inc. stockRetirement Planning Watchlist For Every Investor - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

What catalysts could drive SELLAS Life Sciences Group Inc. stock higher in 2025Wealth Building Trend Scanner For Smart Trading - Jammu Links News

Aug 01, 2025
pulisher
Jul 31, 2025

Published on: 2025-07-31 14:02:06 - beatles.ru

Jul 31, 2025
pulisher
Jul 30, 2025

Sector Leaders Rotate Capital Into SELLAS Life Sciences Group Inc.Stock Screener With Smart Filters Highlights Top Picks - beatles.ru

Jul 30, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 08:30:26 - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

What risks could impact SELLAS Life Sciences Group Inc. stock performanceIntraday Trend Analysis for Fast Gains Released - beatles.ru

Jul 28, 2025
pulisher
Jul 28, 2025

Should I hold or sell SELLAS Life Sciences Group Inc. stock in 2025Market Forecast Updates That Work - Jammu Links News

Jul 28, 2025
pulisher
Jul 27, 2025

How strong is SELLAS Life Sciences Group Inc. company’s balance sheetFree Technical Analysis Support - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How Resilient Is SELLAS Life Sciences Group Inc. Stock During Economic DownturnsTop Performer Shortlist - metal.it

Jul 27, 2025
pulisher
Jul 25, 2025

SELLAS Life Sciences Group Inc. Stock Analysis and ForecastTriple-digit profit margins - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What institutions are buying SELLAS Life Sciences Group Inc. stock nowStrong return on assets - Jammu Links News

Jul 25, 2025
pulisher
Jul 25, 2025

What drives SELLAS Life Sciences Group Inc. stock priceUnprecedented growth rates - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Is SELLAS Life Sciences Group Inc. a good long term investmentExceptional profit potential - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 23, 2025

What drives USEA stock priceMassive wealth growth - Jammu Links News

Jul 23, 2025

Sellas Life Sciences Group Inc (SLS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$78.39
price up icon 0.24%
$37.58
price up icon 1.54%
$109.55
price up icon 0.23%
$28.66
price up icon 2.10%
$111.66
price up icon 0.28%
biotechnology ONC
$288.18
price down icon 3.39%
자본화:     |  볼륨(24시간):